1. Home
  2. BROS vs ALKS Comparison

BROS vs ALKS Comparison

Compare BROS & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dutch Bros Inc.

BROS

Dutch Bros Inc.

HOLD

Current Price

$51.10

Market Cap

8.5B

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$49.09

Market Cap

8.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BROS
ALKS
Founded
1992
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
8.7B
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
BROS
ALKS
Price
$51.10
$49.09
Analyst Decision
Strong Buy
Buy
Analyst Count
20
14
Target Price
$76.40
$43.43
AVG Volume (30 Days)
4.2M
1.6M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
88.24
N/A
EPS
0.41
N/A
Revenue
$1,638,159,000.00
$1,475,899,000.00
Revenue This Year
$27.34
$24.26
Revenue Next Year
$23.01
$4.47
P/E Ratio
$126.76
N/A
Revenue Growth
27.88
N/A
52 Week Low
$44.58
$25.17
52 Week High
$74.65
$55.67

Technical Indicators

Market Signals
Indicator
BROS
ALKS
Relative Strength Index (RSI) 39.38 49.72
Support Level $49.89 $47.66
Resistance Level $54.45 $51.25
Average True Range (ATR) 1.96 1.49
MACD 0.05 -0.08
Stochastic Oscillator 47.07 50.92

Price Performance

Historical Comparison
BROS
ALKS

About BROS Dutch Bros Inc.

Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies, and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company-operated shops.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: